- Home
- NRXS vs DLHC Comparison
NRXS vs DLHC Comparison
Compare NRXS & DLHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NRXS | DLHC |
|---|---|---|
| Founded | 2011 | 1969 |
| Country | United States | United States |
| Employees | N/A | 2300 |
| Industry | | Business Services |
| Sector | | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 78.9M | 87.4M |
| IPO Year | 2023 | 2012 |
Fundamental Metrics
Financial Performance| Metric | NRXS | DLHC |
|---|---|---|
| Price | $7.15 | $5.19 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $13.00 | N/A |
| AVG Volume (30 Days) | ★ 108.9K | 7.4K |
| Earning Date | 05-12-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 22.13 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $3,569,282.00 | ★ $41,923,000.00 |
| Revenue This Year | $172.91 | N/A |
| Revenue Next Year | $115.71 | $0.05 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 32.89 | 2.57 |
| 52 Week Low | $2.20 | $5.44 |
| 52 Week High | $9.33 | $8.09 |
Technical Indicators
Market Signals| Indicator | NRXS | DLHC |
|---|---|---|
| Relative Strength Index (RSI) | 52.31 | 31.11 |
| Support Level | $7.17 | N/A |
| Resistance Level | $7.79 | $5.80 |
| Average True Range (ATR) | 0.35 | 0.08 |
| MACD | 0.05 | -0.01 |
| Stochastic Oscillator | 89.13 | 24.51 |
Price Performance
Historical ComparisonAbout NRXS Neuraxis Inc.
Neuraxis Inc is a growth stage company is engaged in developing neuromodulation therapies to address chronic and debilitating conditions in children. The company is dedicated to advancing the science with its' proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. The company focuses on targeted therapies for the pediatric and adolescent population suffering from disorders of gut-brain interaction (DGBIs).
About DLHC DLH Holdings Corp.
DLH Holdings Corp delivers health and readiness solutions for federal government customers through digital transformation and cyber security, science research and development, and systems engineering and integration. It provides technology-enabled business process, program management, and digital transformation solutions to U.S. government agencies, focusing on large-scale, technology-powered health and defense initiatives for agencies including HHS, VA, DoD, and their sub-agencies. Its revenues come from technology-enabled business process outsourcing, program management solutions, and public health research and analytics under time-and-materials, cost-reimbursable, and firm-fixed-price contracts.